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ABSTRACT. Background and aims: The impact of
chronic airway disease on the health status of elderly
patients is only to some extent explained by indexes
of airflow limitation. The present study was de-
signed to assess to what extent: 1) asthma, chronic
obstructive pulmonary disease (COPD) and chronic
bronchitis with normal FEV1 (simple bronchitis) dif-
fer in their impact on health status; 2) health status
depends upon non-respiratory factors. Methods: A
total of 1601 outpatients over 65 – 198 with asthma,
228 with COPD, 91 with simple bronchitis, and
1084 with non-respiratory illnesses (control group) –
were studied by collection of five health status in-
dexes and multidimensional assessment. Discrimi-
nant analysis was used to identify health status pro-
files of groups. Demographic, anthropometric, clin-
ical and respiratory function correlates of selected
health status profiles were identified. Results: Only
26 and 28% of asthma and COPD patients vs 43%
of simple bronchitis and 50% of non-respiratory
patients showed group-specific health status pro-
files. These profiles were characterized by lower 6-
min walked distance and greater index of disturbed
sleep in asthmatics, and by worse performance on
Barthel Index, 6-min walking test and Mini-Mental
State Examination in COPD patients. More severe
bronchial obstruction, a greater index of comorbid-
ity and a longer occiput-wall distance characterized
COPD patients with the worst health status. Con-
clusions: The health status of elderly patients with
COPD or asthma is highly heterogeneous. On aver-
age, COPD is characterized by more severe physical
impairment, and asthma by poorer quality of sleep.
Comorbidity and severity of bronchial obstruction,
but not age, contribute toward defining a subset of
COPD patients with the worst health status.   
(Aging Clin Exp Res 2004; 16: 26-33)
©2004, Editrice Kurtis
INTRODUCTION
Health status encompasses health-related quality of life
and functional status (1). Instruments assessing health
status are commonly defined as health outcomes be-
cause they are primarily devoted to measuring the out-
come of health care. Moreover, health outcomes can
improve the prediction of clinical outcomes, such as
mortality and onset of disability, as well as the use of re-
sources in various clinical settings (2-7).
Both generic and disease-specific instruments assess-
ing health outcomes have been shown to be weak cor-
relates of Forced Expiratory Volume in the first second
(FEV1) and Forced Vital Capacity (FVC) in patients with
chronic airflow obstruction (8). Furthermore, pharma-
cological or rehabilitation therapy can improve health out-
comes, as assessed by an instrument assessing health-re-
lated quality of life, even in the absence of any measurable
effect on respiratory function indexes (9, 10). The high-
ly subjective dimension of health-related quality of life and
its dependence on the coping behavior and comorbidity
in elderly patients with chronic obstructive pulmonary dis-
ease (COPD) may explain how perceived health status im-
proves in the absence of measurable changes in respira-
tory function and physical performance (11-13). Analo-
gously, dyspnoea and depression, but not forced expira-
tory volume, contribute to explaining most of the variance
in a disease-specific health status index in a population of
elderly asthmatics (14).
The present study was designed to assess health sta-
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tus by selected functional status indexes, with the intent
of limiting the impact of subjectivity on the measured
outcomes.
We aimed at verifying whether three expressions of
chronic airway disease – COPD, asthma, chronic bron-
chitis uncomplicated by bronchial obstruction, i. e.,
simple bronchitis – differ in their effects on the health
status of older patients. We hypothesized that asthma,
due to its fluctuating course, would impact on the av-
erage health status less than COPD, and that simple
bronchitis would have the least effect on health status
because it does not affect airway caliber. With regard to
individual dimensions of health status, we hypothe-
sized that asthma mainly affected the quality of sleep be-
cause of its high rate of nocturnal exacerbation (15).
Conversely, due to its respiratory and systemic effects,
COPD  was expected to outweigh asthma in limiting
both basic and submaximal physical performance (16).
A further objective of the study was to compare the
health status of respiratory patients with that of patients
seeking medical care for non-respiratory diseases in an at-
tempt to clarify the following topics: whether and to
what extent a given respiratory condition has typical
and/or predictable effects on health status; which func-
tional status index can most effectively discriminate pa-
tients with different types of chronic airway disease; and
what role comorbidity plays in conditioning the health sta-
tus of older patients with airflow limitation. 
METHODS
The Sa.R.A. (Salute Respiratoria nell’Anziano= Res-
piratory Health in the Elderly), a multi-center research pro-
ject involving 24 geriatric or pulmonary institutions
throughout Italy (17), was designed to assess various as-
pects of chronic airway disease in the elderly. The study
protocol was approved by the Ethical Committees of
the participating institutions. Patients gave their written in-
formed consent to participate in the study.
The present analysis focuses on the effects of chronic
airway disease on health status. 
Subjects
Cases: Subjects were all outpatients aged 65 years
and over, referred consecutively to the above-cited insti-
tutions between January 1 1996 and July 15 1997, be-
cause of a previous diagnosis of asthma or COPD or be-
cause of signs and/or symptoms compatible with either di-
agnosis. Diagnoses were checked by a diagnostic protocol
based on a modified International Union Against Tuber-
colosis and Lung Diseases (IUATLD) questionnaire and on
spirometry followed by the reversibility test (17, 18). Da-
ta collected were entered into an algorithm aimed at clas-
sifying patients into three categories: COPD, asthma and
simple bronchitis (Fig. 1). The last definition applies to sub-
jects with symptoms of chronic bronchitis according to CI-
BA criteria but FEV1>80% of the predicted value. Note
that the CIBA criteria define chronic bronchitis as “the con-
Figure 1 - Algorithm used for classifying respiratory patients into one of three diagnostic groups: asthma, COPD, non-obstructive bron-
chitis (simple bronchitis). *CIBA criteria: see Methods (Subjects).
Cases
<80FEV1   % predicted>80
– CIBA criteria +
Simple bronchitis
(non-obstructive)– Wheeze in the last year +
AsthmaExclusion from the study
– CIBA criteria +
COPD– Wheeze in the last year +
AsthmaFEV1  increase > 12% after 100 mcg fenoterol
Yes No
Asthma COPD
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dition of subjects with chronic or recurrent mucus secretion
into the bronchial tree”, i.e., a condition “occurring on
most days of at least three months of the year for at
least two successive years” (19).
Controls: We recruited subjects aged 65 years and
over consecutively attending the outpatient geriatric de-
partments in the same time period, but not reporting any
previous diagnosis of respiratory disease or any symptoms
or signs compatible with such a diagnosis.
Exclusion criteria from both study and control groups
were: severe liver failure, corresponding to B or C grades
of the Child index (20); New York Heart Association
(NYHA) class III or IV cardiac failure (21); severe renal fail-
ure (serum creatinine*2 mg/L); cognitive and/or senso-
ry impairment severe enough to prevent multidimen-
sional assessment; occurrence of a major psychosocial
event (e.g., bereavement) within the past 6 months; hos-
pitalization for any reason within the past 6 months.
Procedures 
Subjects were investigated according to a protocol cov-
ering the following domains: social and environmental as-
pects; smoking history; pharmacological therapy, which was
assessed and codified according to a previously validated
method (22, 23); comorbid diseases, which were classified
following the International Disease Classification, 9th revision,
Clinical Modification, and combined to compute Charl-
son’s Index of comorbidity (24, 25); anthropometric data
[(weight, height, Body Mass Index (BMI=weight/height2)];
waist-to-hip ratio, and occiput-wall distance (26-28). The last
index reflects the degree of kyphosis of the upper tho-
racic and cervical spine, which is a correlate of both poor
balance and osteoporotic vertebral fractures (26, 27).
Spirometry was performed by a fully-computerized
water-sealed Stead-Wells spirometer (Baires, Biomedin,
Padova, Italy) meeting the ATS 1994 recommendations
for diagnostic spirometry (29). Patients having FEV1<80%
of the predicted value underwent a reversibility test with
inhaled fenoterol, 100 mcg (17).
The following health outcomes were measured:
1) The Barthel Index was used to explore independence
in basic activities of daily living (30). The final score may
range between 0 (complete dependence) and 100
(complete independence).  
2) The 6-min walked distance was assumed to be a mea-
sure of submaximal physical performance (31). Pa-
tients were asked to walk back and forth at their maxi-
mal pace down a 20-m long hospital corridor. They
were allowed to rest if they felt exhausted, but the
time spent resting could not be made up. Standard
encouragement was given on each lap. The distance cu-
mulatively covered in 6 min was recorded for analysis.  
3) Mini-Mental State Examination (MMSE) was used to
quantify cognitive performance. Normal subjects usu-
ally score 24 or more (32).  
4) The 15-item Short Form of the Geriatric Depression
Scale (15-GDS) was administered to assess affective sta-
tus. A score over 5 is considered to be diagnostic of de-
pressed mood (33). 
5) The Established Populations for Epidemiological Stud-
ies of the Elderly (EPESE) questionnaire was used to rate
sleep disturbances (34). The frequency of four types of
sleep disturbances (difficulty initiating sleep, waking at
night, feeling of tiredness after morning waking, waking
too early) is graded according to the following 5-step
score: 0=never; 1=occasionally (less than once a week);
Table 1 - Differences in sociodemographic, anthropometric and clinical variables among groups.
Asthma COPD Simple bronchitis Controls
N=198 N=228 N=91 N=1084
Age, M (SD) 72.7 (6) 72.9 (5.7) 73.7 (5.7) 73.6 (6.3) F=1.55, p=0.2
Sex, % females 53.5 16.9 29.3 48.8 χ=117, p<0.001
No heating, % 7 7.9 3 2.8 χ=17.4, p<0.001
Living alone, % 31.4 22.7 25.5 30.3 χ=6.31, p=0.097
Lower formal education, % 77.2 87.7 82.7 77.4 χ=13.1, p=0.004
Smokers, (no): -never 91 27 26 516
-actual 21 42 23 101 χ=144.5, p<0.001
-previous 84 161 50 367
Pack-years, M (SD)* 20.8 (32.8) 46.2 (40.4) 26.3 (30.2) 14 (23.7) F=8.03, p<0.001
BMI, Kg/cm2, M (SD) 27.9 (4.9) 25.6 (4) 26.2 (4.3) 26.4 (4.2) F=11.52, p<0.001
BMI<22, Kg/cm2, % 7.6 17.8 9 15.5 χ=11.3, p=0.01
Waist-to-hip ratio, M (SD) 0.95 (0.11) 0.97 (0.096) 0.94 (0.083) 0.95 (0.13) F=3.45, p=0.02
Index of comorbidity, M (SD) 1.55 (1.45) 1.45 (1.38) 1.9 (1.5) 1.5 (1.3) F=2.86, p=0.04
Drugs used, no., M (SD) 3.6 (2.1) 3.9 (2.2) 2.9 (1.9) 2.1 (1.7) F=75.9, p<0.001
χ= chi square; * (no. of cigarettes smoked daily) / 20 x (no. of years of smoking).
2=sometimes (once or twice a week); 3=often (three
times or more in the week); 4=always. Thus, the global
score can range between 0 and 16 (34).
No disease-specific instrument was used for the present
analysis, because it could not be applied to non-respiratory
patients.
Statistical analysis
The Epi Info (CDC, Atlanta, USA, and WHO, Gene-
va, Switzerland) and BMDP (University of California,
Berkeley, California) statistical packages were used. 
Differences among groups in the distribution of collected
variables were assessed by the χ2 test for dichotomous da-
ta and by analysis of variance for continuous data. 
Health outcome variables were entered into a dis-
criminant analysis aimed at identifying subjects with sim-
ilar health status profiles, as defined by the combination
of scores achieved on individual indexes, within each
group. The greater this fraction of patients in a given
group, the more typical the health status profile of that
group may be considered. The rate of concordance be-
tween actual group membership, as defined by the se-
lecting criteria, and functional group membership, re-
sulting from health status profiles, was computed. In a 4
by 4 cross-tabulation, corresponding to the four actual
groups by the four functional groups, a rate of concor-
dance of up to 25% was expected to occur by chance,
whereas a figure greater than 25% for a given actual
group was consistent with that group having a distinctive
health status profile. The strength of the discriminant
function was assessed by Wilk’s lambda, which is a mea-
sure of significance of the discriminant function (35).
The contribution of any individual variable to the dis-
criminant function was assumed to be proportional to the
absolute value of the coefficient of correlation between the
discriminating variable and the discriminant function (35).
RESULTS
Twenty-five respiratory patients could not satisfactorily
perform and 6 refused to perform spirometry, and were
thus excluded from the study. The corresponding fig-
ures for control groups were 67 and 6. Of the remaining
1501 patients, 198 qualified as being affected by asthma,
228 by COPD, 91 by simple bronchitis, and 1084 by
Table 2 - Differences in health outcome variables (rows 2 to 6) and respiratory function indexes (rows 7 to 9) among groups.
Asthma COPD Simple bronchitis Controls F, p
N=198 N=228 N=91 N=1084
Barthel Index, M (SD) 92.5 (8.5) 92.2 (7.3) 95 (5.1) 94.7 (6.7) 11.9, <0.001
6’ walked distance, m, M (SD) 304 (127) 300 (123) 346 (119) 336 (125) 7.56, <0.001
MMSE, M (SD) 27.1 (3.4) 26.4 (3.7) 26.9 (3.8) 27 (3.3) 2.14, =0.09
GDS, M (SD) 4.3 (3.6) 4.2 (3.1) 4.7 (3.9) 3.6 (3.3) 6.12, <0.001
Index of disturbed sleep, M (SD) 4.9 (4.6) 3.9 (4.5) 4.4 (4.3) 3.6 (4) 5.66, <0.001
FEV1/FVC, M (SD) 62.5 (13.8) 40.5 (14.2) 71.2 (9.1) 75.5 (8.6) 369, <0.001
FEV1, % predicted, M (SD) 70.1 (24.4) 51.6 (16.3) 98.8 (14.8) 99.8 (19.6) 435, <0.001
FVC, % predicted, M (SD) 82.1 (20.9) 75.6 (17.7) 101.1 (12.4) 97.1 (17.6) 116, <0.001
Table 3 - Results of discriminant analysis: canonical discriminant functions (upper panel) and determinants of discriminant functions
(lower panel).
A. Canonical discriminant functions
Function Eigen-value % of variance Wilk’s lambda Significance
1 0.046 68.8 0.935 p<0.001
2 0.015 21.7 0.979 p<0.001
3 0.006 9.5 0.994 p<0.03
B. Contribution of individual health outcomes to discriminant functions. Absolute value of standardized coefficients of correlation within func-
tions reflects strength of correlation.
Function 1 Function 2 Function 3
Barthel Index 0.861 0.185 0.239
6’ walked distance 0.249 0.364 -0.645
MMSE -0.158 0.422 0.574
GDS -0.106 0.862 -0.523
Quality of sleep -0.169 0.274 0.628
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chronic non-respiratory diseases (controls). Control pa-
tients most commonly suffered from coronary artery dis-
ease-myocardial infarction (13.9%), congestive heart fail-
ure (6.3%), peripheral arterial vascular disease (4.1%), os-
teoarthritis (26.8%), diabetes mellitus (12%), neurologic
diseases (7.1%) and malignant tumors (5.2%). 
Demographic, anthropometric, and clinical variables are
listed in Table 1. Groups were comparable by age, where-
as males, ex-smokers and current smokers prevailed in the
COPD and simple bronchitis groups. These two groups
were also characterized by lower formal education. Sev-
en percent of asthmatics and 7.9% of COPD patients, but
only 3% of simple bronchitis and 2.7% of control patients,
lacked a domestic heating system (p<0.001). COPD pa-
tients had the lowest average BMI and the highest fraction
of subjects with BMI<22 Kg/cm2 (17.8%), but the high-
est waist-to-hip ratio, which is an index of central obesi-
ty. The simple bronchitis group was characterized by
the highest index of comorbidity; no differences were
found among the remaining groups. 
Table 2 compares health outcome variables and res-
piratory function indexes of groups. The asthma and
COPD groups had comparable impairment in physical
function, as reflected by both the Barthel Index and 6-min
walked distance; performances were poorer than those
achieved by simple bronchitis and control subjects. All
groups had similar MMSE scores. The highest and lowest
average score on the 15-GDS characterized simple bron-
chitis (4.7±3.9) and control groups (3.6±3.3), respectively.
Asthmatics had the worst quality of sleep. Bronchial ob-
struction was mild to moderate in the majority of COPD
patients: only 6% had a FEV1<35% of that predicted.  
The results of discriminant analysis are listed in Tables
3 and 4. Three discriminant functions were obtained, the
first and second of which explained 68.8 and 21.7% of
the variance, respectively (Table 3, upper panel). The sig-
nificant Wilk’s lambda coefficients state that discrimi-
nant functions reflect real differences among groups and
not sampling variability. The high Wilk’s lambda values al-
so demonstrate that a large proportion of total variance
in the discriminant scores is explained by variance within
individual groups. An index exploring physical fitness, the
Barthel Index, and one reflecting mood, the 15-GDS,
were the main determinants of discriminant functions 1
and 2, respectively. The second most important deter-
minant of function 1, the 6-min walked distance, further
explored physical fitness (Table 3, lower panel). 
Table 4 cross-tabulates actual group membership, as
defined by classificatory criteria, and functional group
membership, resulting from the distribution of explored
health outcomes. Only 28% of COPD and 26% of asth-
ma patients (actual groups) were classified as belonging to
the COPD and asthma functional groups, respectively.
This finding shows that asthma and COPD are not char-
acterized by distinctive health status. The 43% and 50%
degree of agreement between actual and functional group
Table 4 - Results of discriminant analysis: cross-tabulation of actual group membership, as defined by selection criteria (rows), and func-
tional group membership, as defined by health outcome profile (columns).
Functional group %
Actual group, % Asthma COPD Simple bronchitis Controls
Asthma 25.6 19.3 23.9 31.3
COPD 17.2 28.1 22.7 32
Simple bronchitis 11 8.8 42.9 37.4
Controls 14.3 10.1 25.1 50.4
Box’s M=177.5, p<0.001.
Table 5 - Distribution of health outcomes in respiratory patients, subgrouped according to whether individual health outcome profiles
conform to (C) or differ from (D) group-specific profiles.
Asthma COPD Simple bronchitis
C D p C D p C D p
Barthel Index 93.5 (6.8) 94.3 (4.5) 0.47 85 (6.9) 96 (2.6) <0.001 94.6 (5.1) 96.4 (2.1) 0.47
6’ walked distance, m 248 (109) 325 (128) <0.001 265 (112) 325 (119) <0.001 385 (127) 328 (104) 0.05
MMSE 28.2 (2.2) 27.3 (2.8) 0.054 25.7 (3.0) 27.4 (2.5) <0.001 27.7 (2.6) 27.4 (2.8) 0.65
GDS 4.2 (3.2) 4.3 (3.7) 0.89 4.4 (3.2) 4.1 (3.1) 0.59 7.8 (3.7) 2.6 (2.3) <0.001
Index of disturbed sleep 8.4 (4.0) 3.6 (4.0) <0.001 3.4 (4.4) 4.1 (4.4) 0.29 6.3 (4.9) 2.9 (3.1) <0.001
Data are expressed as means; standard deviation in brackets.
membership for simple bronchitis and control subjects is
much higher than the 25% figure expected on the basis
of chance classification. Both simple bronchitis and con-
trol subjects had low percentages of functional classifica-
tions in the asthma and COPD groups. 
The distribution of health outcomes in respiratory pa-
tients subgrouped according to whether individual health
outcome profiles conformed to (C) or differed from (D)
group-specific profiles is listed in Table 5. A typical
group-specific health outcome profile was characterized
by lower 6-min walked distance and greater index of
disturbed sleep in asthmatics, and by worse performance
on the Barthel Index, the 6-min walking test and the
MMSE in COPD patients. Depressed mood and dis-
turbed sleep were the hallmarks of the group-specific
health outcome profile of simple bronchitis patients.
Patients with and without group-specific health out-
come profiles had comparable demographic, respiratory
function and clinical variables in both asthma and simple
bronchitis groups. A longer occiput-wall distance (7.5±3.8
vs 6.1±3.7 cm, p<0.05), higher comorbidity index
(1.5+1.4 vs 1.1+1.2, p<0.03) and more severe chronic
obstruction (FEV1%=46.3+15.4 vs 54.1+16.5, p<0.01)
were associated with group specificity, i.e., with worse
health outcome profiles, in the COPD group. 
DISCUSSION
This study shows that the selected dimensions of
health status were differently affected by asthma and
COPD in the elderly. However, neither asthma nor
COPD were associated with a distinctive health status, as
if their effects on the health status of older patients were
frequently undistinguishable from those of simple bron-
chitis or non-respiratory diseases. The best health status
characterized patients with simple bronchitis, i.e., with
symptoms of bronchitis in the absence of airflow limita-
tion, whereas the worst was observed in the COPD sub-
set characterized by greater comorbidity and more severe
airflow limitation, but not by older age.
The great heterogeneity in health status profiles within
COPD and asthma groups probably reflects the complex in-
teraction of factors conditioning disease-related health sta-
tus in the elderly. Indeed, indexes of physical fitness, which
explained most of the variance among groups, partially de-
pended upon non-respiratory clinical variables: a longer oc-
ciput-wall distance, which reflects the severity of osteo-
porosis, and a higher index of comorbidity characterized
COPD patients with worse health outcome profiles. Health
status was unrelated to social or demographic variables,
probably because the vast majority of COPD and asthma
patients suffered from mild to moderate chronic airflow lim-
itation, lived with their relatives, and could benefit by in-
formal support. In more advanced stages of the respirato-
ry disease, social factors are expected to impact more on
the provision of help and, consequently, on health out-
comes. Lastly, the relatively narrow age interval, due to the
selection criteria, probably contributed toward weakening
the relationship between age and health status. However,
results from previous studies on older COPD populations
support the conclusion that FEV1 limitation outweighs
age as a negative correlate of health status (12, 36).
Depressed mood and disturbed sleep were the main
components of health outcome profiles in simple bron-
chitis, but not in COPD. Thus, psychological problems
seem to account for most of the variability in health sta-
tus prior to the onset of airflow limitation; thereafter, phys-
ical limitation and cognitive impairment characterize pa-
tients with poorer health status. 
The health outcome profiles of asthmatics differed
from those of COPD patients because they strictly re-
flected quality of sleep and 6-min walked distance. The cir-
cadian rhythm of airflow limitation, leading to mainly
nocturnal exacerbations of asthma, explains the former re-
lationship (37). Most asthmatics were completely inde-
pendent in activities of daily living, so that inter-individu-
al differences could be seen to emerge in the 6-min
walking test but not in the Barthel Index. 
The differences in health status between simple bron-
chitis and COPD or asthma patients testify to the lack of
a definite impact of the respiratory condition on health sta-
tus prior to the onset of airflow limitation. When com-
pared with simple bronchitis patients, both COPD and
asthma patients had worse health status; however, this
does not translate into a distinctive health status profile be-
ing highly prevalent within any of these groups. Both the
choice of using a control non-respiratory population rep-
resentative of usual and not of successful aging and the
heterogeneous nature of COPD and asthma probably ex-
plain this seeming paradox (38-40). 
This study has some limitations which deserve to be cit-
ed: 1) Distinction of asthma from COPD in the elderly is
not easy (41, 42). Our algorithm represents a logical at-
tempt at classifying these patients, but some weaknesses
cannot be excluded. 2) The strength of a discriminant
model depends largely upon the adequacy of the dis-
criminating variables. We used assessment instruments
which had been repeatedly validated in broad geriatric
populations, but not in elderly respiratory patients, except
for a study limited to 135 asthmatics (43). 3) The present
results apply to patients with mild to moderate chronic air-
way disease, because severely diseased patients, whose
hallmarks are greater comorbidity and lower physical
capabilities, are underrepresented in this study (44).
CONCLUSIONS
Large inter-individual differences exist in disease-related
health status among elderly patients with chronic respi-
ratory diseases. Future research should aim at verifying
whether differences in health status have prognostic im-
plications as well as identifying the assessment instruments
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achieving the best discrimination. The recent demon-
stration that selected dimensions of quality of life are
highly correlated with the frequency of COPD exacerba-
tions emphasizes the need to pursue this research line
(45). Eventually, close follow-up of these patients will
allow us identify the meaning of clinical conditions, such
as simple bronchitis or COPD with partially reversible ob-
struction, the evolution of which cannot be predicted
on the basis of presently available knowledge.
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The SaRA Study Group: list of participants
Coordinators: V. Bellia (Palermo), F. Rengo (Napoli).
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D. Olivieri (Parma), M. Palleschi (Roma), R. Pistelli (Roma), M. Tra-
bucchi (Roma), S. Zuccaro (Roma).
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Consales (D. Lo Nardo, P. Paggi); (2) Divisione Geriatria, Ospedale
Civile, Asti: F. Goria (P. Fea, G. Iraldi, R. Corradi); (3) Cattedra
Geront. e Geriatria, Policlinico Universitario, Bari: A. Capurso (R. Flo-
ra, S. Torres, G. Venezia, M. Mesto); (4) V Divisione Geriatria, 
Ospedale Malpighi, Bologna: S. Semeraro (L. Bellotti, A. Tansella); (5)
I Divisione Medicina Generale, Ospedale Civile, Brescia: V. Grassi (S.
Cossi, G. Guerini, C. Fantoni, M. De Martinis, L. Pini); (6) Clinica Pneu-
mologica, Fondazione “E. Maugeri”, Telese (BN): G. Melillo (R. Bat-
tiloro, C. Gaudiosi, S. De Angelis);  (7) Istituto Medicina Interna e Geri-
atria, Ospedale Cannizzaro, Catania: L. Motta (I. Alessandria, S.
Savia); (8) Istituto Gerontologia e Geriatria, Ospedale Ponte Nuovo, Uni-
versità di Firenze: G. Masotti (M. Chiarlone, S. Zacchei); (9) Divi-
sione Geriatria, Ospedale Morgagni, Forlì: V. Pedone (D. Angelini, D.
Cilla); (10) Divisione Geriatria, Ospedale Galliera, Genova: E. Palum-
meri (M. Agretti, P. Costelli, D. Torriglia); (11) Gruppo Ricerca Geri-
atrica, Ospedale Richiedei, Gussago (BS): M. Trabucchi (P. Barbi-
soni, F. Guerini, P. Ranieri); (12) Divisione Geriatria, Ospedale 
Generale, L’Aquila: F. Caione (D. Caione, M. La Chiara); (13) I Divi-
sione Geriatria, Ospedale San Gerardo, Monza: G. Galetti (A. Can-
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